(19)
(11)
EP 1 551 446 A1
(12)
(43)
Date of publication:
13.07.2005
Bulletin 2005/28
(21)
Application number:
02744407.4
(22)
Date of filing:
18.06.2002
(51)
International Patent Classification (IPC)
7
:
A61K
39/00
,
A61K
39/385
,
C12N
15/85
,
C12N
15/86
,
C12N
15/63
,
C07K
7/00
,
C07K
14/00
(86)
International application number:
PCT/US2002/019237
(87)
International publication number:
WO 2003/105892
(
24.12.2003
Gazette 2003/52)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI
(71)
Applicant:
University of Kansas Medical Center
Kansas City, KS 66160-7702 (US)
(72)
Inventor:
SHAH, Girish, V.
Amarillo, TX 79109 (US)
(74)
Representative:
Crump, Julian Richard John et al
Mintz Levin Cohn Ferris Glovsky and PopeoIntellectual Property LLPThe Rectory9, Ironmonger Lane
London EC2V 8EY
London EC2V 8EY (GB)
(54)
NEUROENDOCRINE MARKER FOR CANCER AND METHOD FOR PRODUCING SAME